Morepen Laboratories Limited
Morepen Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: MOREPENLAB and BSE: 500288 (ISIN INE083A01026).
It has a market capitalisation of ₹6,657 crore, a last close of ₹121.49 on 2026-10-19, a one-year return of 152.6%.
Valuation: a price-to-book ratio of 5.34x, a dividend yield of 0.2%.
Profitability: return on equity of 0.0%, return on capital employed of 10.0%, an operating margin of 9.4%.
Growth: sales growth of 8.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.16x, promoter holding of 35.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 6,657 |
| Last close | ₹121.49 |
| P/B | 5.34x |
| Dividend yield | 0.2% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 10.0% |
| Operating margin (TTM) | 9.4% |
| Sales growth, 3-year CAGR | 8.4% |
| Debt / equity | 0.16x |
| Promoter holding | 35.7% |
| 1-year return | 152.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means